These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23246245

  • 1. Effects of cannabis use status on cognitive function, in males with schizophrenia.
    Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP.
    Psychiatry Res; 2013 Apr 30; 206(2-3):158-65. PubMed ID: 23246245
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.
    Coulston CM, Perdices M, Tennant CC.
    Schizophr Res; 2007 Nov 30; 96(1-3):169-84. PubMed ID: 17826035
    [Abstract] [Full Text] [Related]

  • 5. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA, Vaskinn A, Sundet K, Engh JA, Jónsdóttir H, Simonsen C, Friis S, Opjordsmoen S, Melle I, Andreassen OA.
    Psychol Med; 2010 Aug 30; 40(8):1337-47. PubMed ID: 19891810
    [Abstract] [Full Text] [Related]

  • 6. No additive effect of cannabis on cognition in schizophrenia.
    Power BD, Dragovic M, Badcock JC, Morgan VA, Castle D, Jablensky A, Stefanis NC.
    Schizophr Res; 2015 Oct 30; 168(1-2):245-51. PubMed ID: 26235754
    [Abstract] [Full Text] [Related]

  • 7. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F, Verdoux H.
    Encephale; 2002 Oct 30; 28(2):160-8. PubMed ID: 11972143
    [Abstract] [Full Text] [Related]

  • 8. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
    Rodríguez-Sánchez JM, Ayesa-Arriola R, Mata I, Moreno-Calle T, Perez-Iglesias R, González-Blanch C, Periañez JA, Vazquez-Barquero JL, Crespo-Facorro B.
    Schizophr Res; 2010 Dec 30; 124(1-3):142-51. PubMed ID: 20826079
    [Abstract] [Full Text] [Related]

  • 9. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH.
    Aust N Z J Psychiatry; 2010 Mar 30; 44(3):230-6. PubMed ID: 20180725
    [Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O, Feinstein A.
    Neurology; 2008 Jul 15; 71(3):164-9. PubMed ID: 18272863
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.
    Scholes KE, Martin-Iverson MT.
    Psychol Med; 2010 Oct 15; 40(10):1635-46. PubMed ID: 20018124
    [Abstract] [Full Text] [Related]

  • 13. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Jockers-Scherübl MC, Wolf T, Radzei N, Schlattmann P, Rentzsch J, Gómez-Carrillo de Castro A, Kühl KP.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1054-63. PubMed ID: 17482741
    [Abstract] [Full Text] [Related]

  • 14. Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.
    Sánchez-Torres AM, Basterra V, Rosa A, Fañanás L, Zarzuela A, Ibáñez B, Peralta V, Cuesta MJ.
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec 30; 263(8):643-53. PubMed ID: 23580110
    [Abstract] [Full Text] [Related]

  • 15. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
    van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M.
    Drug Alcohol Depend; 2013 Dec 01; 133(2):352-9. PubMed ID: 23886472
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
    Rentzsch J, Buntebart E, Stadelmeier A, Gallinat J, Jockers-Scherübl MC.
    Schizophr Res; 2011 Aug 01; 130(1-3):222-7. PubMed ID: 21624823
    [Abstract] [Full Text] [Related]

  • 17. History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders.
    Menendez-Miranda I, Garcia-Alvarez L, Garcia-Portilla MP, Gonzalez-Blanco L, Saiz PA, Bobes J.
    Eur Addict Res; 2019 Aug 01; 25(3):111-118. PubMed ID: 30897572
    [Abstract] [Full Text] [Related]

  • 18. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
    Dekker N, Smeerdijk AM, Wiers RW, Duits JH, van Gelder G, Houben K, Schippers G, Linszen DH, de Haan L.
    Psychol Med; 2010 Aug 01; 40(8):1325-36. PubMed ID: 19917142
    [Abstract] [Full Text] [Related]

  • 19. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.
    Rabin RA, Barr MS, Goodman MS, Herman Y, Zakzanis KK, Kish SJ, Kiang M, Remington G, George TP.
    Neuropsychopharmacology; 2017 Oct 01; 42(11):2259-2271. PubMed ID: 28443616
    [Abstract] [Full Text] [Related]

  • 20. Relationship between tobacco and cannabis use status in outpatients with schizophrenia.
    Rabin RA, Giddens JL, George TP.
    Am J Addict; 2014 Oct 01; 23(2):170-5. PubMed ID: 25187052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.